METABOLIC BONE DISEASE
Composition of Bone
The extracellular matrix
40% organic
 Type 1 collagen
Proteoglycan
Osteocalcin/osteonectin
Growth factors/cytokines
 60% inorganic
Calcium hydroxyapatite
Ca10(PO4)6(OH)2
The cells
Osteo-clast/blast/cytes/progenitors
Bone Turn
over
Calcium
metabolism
 What is recommended daily intake?
 Adult:1000 mg/day
 Pregnancy,lactation,postmenopausal:1.3g/day
 Children (1-18 yrs):0.5-1.3 g/day
 Infant (<1 yr):300-500 mg/day
 What is plasma concentration?
 Total (mg/dL): 8.6-10.3
(mmol/L): 2.15-2.57
 Ionized (mg/dL): 4.5-5.6
(mmol/L): 1.1-1.4
Ref: Harrison’s 18th edition
Phosphate
Metabolism
 What is recommended daily intake?
Infants (< 1yrs): 100-275 mg/day
Children (1-18 yrs): 460-1250 mg/day
Adults:700-1250 mg/day
Pregnancy/lactation: 700-1250 mg/day
 What is plasma concentration?
Adult:2.5-4.5 mg/dL
Children:4-7 mg/dL
Ref: Harrison’s 18th edition
Parathyroid hormone
(PTH)
• Synthesizes and secreted by chief cells of
parathyroid gland
• Synthesized as pre-pro-PTH, cleaved
enzymatically to intact PTH
• Plasma calcium: primary physiological
regulator of PTH synthesis and secretion
• Normal Reference Range: 10 -65
ng/L
Effect on serum levels: increase Ca, decrease P
Target organ Action
Kidney Increase reabsorption of Ca
Increase excretion of P
Bone Increase Ca/P mobilization
from bone
GIT Increase in Ca absorption
by stimulating activation of
Vitamin D
Vitamin
D
• Sources of vitamin D?
Diet
UV light exposure on precursor in skin
• Daily requirement?
400 International units
Target organ Action
Bone Increase Ca mobilisation from bone
GIT Increase in Ca absorption
Effect on serum levels: increase Ca, decrease P
Calciton
in
• Secreted by parafollicular or C cells
distributed throughout thyroid gland
• Normal serum concentration
Men:<8.8 pg/mL
Women:<5.8 pg/mL
• Level Increases when serum Ca concentration
>2.25mmol/L
Ref: Harrison’s 18th edition
Effect on serum levels: decrease Ca, increase P
Target organ Action
Bone Supresses resorption
Kidney Increase excretion of Ca
Alkaline
Phosphate
Present in all tissue, concentrated in liver,
intestins, kidney, bone and placenta
 Normal range: 20 – 140 IU/L
Recent
Markers
Osteoblast
s
Osteoi
d
Osteocyt
e
Bone matrix
Osteocla
st
Markers of bone resorption
(Urine)
Hydroxyproline
Collagen cross-links
Pyridinolines
(pyridinoline,
deoxypyridinoline)
Cross-linked telopeptides (NTx,
CTx) Tartrate-Resistant Acid
Posphate
Markers of bone formation
(serum)
Bone alkaline
phosphatase
Osteocalcin
Procollagen type I propeptides (PINP,
PICP)
Disease with
markers
Disease S. Ca S. PO4 S.PTH S. ALP Recent biomarker
Osteoporosis N N N N/high Cathepsin K
C- telopeptide
Rickets/Osetmalacia Low low high high Osteocalcin
Paget’s disease N N N high --------
Metabolic bone
diseases
heterogeneous group of disorders characterized by abnormalities in
calciummetabolism and/or bone cell physiology. They lead to analtered
serum calcium concentration and/or skeletal failure. The most common
type of metabolic bone disease in developed countries is osteoporosis
• Osteoporosis
• Osteomalacia & Rickets
• Renal Osteodystrophy
Rickets &
Osteomalacia
Rickets is defective mineralization of bones
before epiphysial closure in immature
mammals due to deficiency or impaired
metabolism
of vitamin D, phosphorus or calcium
,potentially leading to fractures and
deformity.
Osteomalacia is a similar condition
occurring in adults, generally due to a
deficiency of vitamin D but occurs after
epiphyseal closure.
Rickets &
Osteomalacia
Vit D deficiency
low intake plus inadequate sunlight exposure
malabsorption
Abnormal vit D metabolism
Liver disease
Renal disease
Drugs(anticonvulsants)
Hypophosphatemia
Low intake
Hypophosphatemic Vitamin D resistant rickets(X-
linked)
• Skeletal deformity
Toddlers: Bowed legs (genu varum)
Older children: Knock-knees (genu
valgum) or "windswept knees"
Cranial deformity (such as skull bossing or
delayed fontanelle closure)
Pelvic deformity
Spinal deformity (such as
kyphoscoliosis or lumbar lordosis)
Rickets &
Osteomalacia
• Lab investigations include :
• S. ALP ↑
• Ca low in Vitamin D deficiency
• Phosphate may be normal or low
• PTH may ↑
OSTEOPOR
OSIS
Common in developed countries
Associated with advanced age
Associated with increased risk of fractures
(hip, vertebrae, forearm)
Exercise & nutrition play an important
role in attaining adequate skeletal mass
During early adult life bone formation =
bone resorption
Aging increases bone resorption
OSTEOPOR
OSIS
• Pathophysiology
 Inadequate bone formation
during growth
 Pathophysiological
process impairing
osteoblastic bone
formation
 Increase in bone resorption
Factors involved in causation
of osteoporosis
Hormones
Poor diet
Genetic factors
Cytokines
Prostaglandins
Growth factors
Low physical activity and low
exposure to sunlight
Osteoporo
sis
• Risk Factors
- Early
menopause
- family history
- Sedentary life
- Low calcium
intake
- Cigarette
smoking
- Excessive
alcohol
- Excessive
- Most commonly
encountered in
post menopausal
females
Clinical
presentations
Back pain
Fractures
Investigations
Routine X-rays
Bone scan
Investigations for secondary
causes
Osteoporosis
(management)
 Exercise
 Calcium
 Vit D
 Bisphosponates
 Oestrogen
replacement
 Androgens
Pagets
Disease
Disease of bone remodelling
osteoclast mediated bone resorption
followed by new bone formation
Cause unknown ?virus (paramyxovirus)
More common in caucasian
Pagets Disease (clinical
manifestation)
Bone pain
Joint pain
Deformity
Spontaneous
fractures
Pagets Disease
(complications)
Fractures
Deafness
Nerve entrapment
Spinal stenosis
Cardiac failure
Osteogenic
sarcoma
Hypercalcemia
Pagets Disease
(investigations)
↑ markers of bone formation
↑ ↑ Serum alk phosphatase
Urinary hydroxy proline and pyridinoline cross
links
X-rays
cortical thikening
osteolytic, & osteiosclerotic
 bone scan
RENAL
OSTEODYSTROPHY
• Associated with CRF
a) ↓excretion of PO4 ---> ↑ PO4
b) Inability of kidney to synthesise 1,25 (OH)2D (↓ renal
mass & ↑ PO4)
c) ↓ intestinal absorption of Ca ---> hypocalcemia
• Results in hyper parathyroidism
RENAL OSTEODYSTROPHY :
CLINICAL
MENIFESTATIONS
• BONE PAINS (WT BEARING)
• SKELETAL DEFORMITIES IN
CHILD
• EXTRACELLULAR
CALCIFICATION
• LAB
INVESTIGATIONS:
 ↑ PO4
 HYPOCALCEMIA
 ↑ PTH
 ↓1,25 (OH)2 D
 ↑ ALP
 Mg ↑
THANKY
O
U

metabolicbonedisease-150401111940-conversion-gate01-converted.pptx

  • 1.
  • 2.
    Composition of Bone Theextracellular matrix 40% organic  Type 1 collagen Proteoglycan Osteocalcin/osteonectin Growth factors/cytokines  60% inorganic Calcium hydroxyapatite Ca10(PO4)6(OH)2 The cells Osteo-clast/blast/cytes/progenitors
  • 3.
  • 4.
    Calcium metabolism  What isrecommended daily intake?  Adult:1000 mg/day  Pregnancy,lactation,postmenopausal:1.3g/day  Children (1-18 yrs):0.5-1.3 g/day  Infant (<1 yr):300-500 mg/day  What is plasma concentration?  Total (mg/dL): 8.6-10.3 (mmol/L): 2.15-2.57  Ionized (mg/dL): 4.5-5.6 (mmol/L): 1.1-1.4 Ref: Harrison’s 18th edition
  • 6.
    Phosphate Metabolism  What isrecommended daily intake? Infants (< 1yrs): 100-275 mg/day Children (1-18 yrs): 460-1250 mg/day Adults:700-1250 mg/day Pregnancy/lactation: 700-1250 mg/day  What is plasma concentration? Adult:2.5-4.5 mg/dL Children:4-7 mg/dL Ref: Harrison’s 18th edition
  • 8.
    Parathyroid hormone (PTH) • Synthesizesand secreted by chief cells of parathyroid gland • Synthesized as pre-pro-PTH, cleaved enzymatically to intact PTH • Plasma calcium: primary physiological regulator of PTH synthesis and secretion • Normal Reference Range: 10 -65 ng/L
  • 9.
    Effect on serumlevels: increase Ca, decrease P Target organ Action Kidney Increase reabsorption of Ca Increase excretion of P Bone Increase Ca/P mobilization from bone GIT Increase in Ca absorption by stimulating activation of Vitamin D
  • 10.
    Vitamin D • Sources ofvitamin D? Diet UV light exposure on precursor in skin • Daily requirement? 400 International units
  • 11.
    Target organ Action BoneIncrease Ca mobilisation from bone GIT Increase in Ca absorption Effect on serum levels: increase Ca, decrease P
  • 12.
    Calciton in • Secreted byparafollicular or C cells distributed throughout thyroid gland • Normal serum concentration Men:<8.8 pg/mL Women:<5.8 pg/mL • Level Increases when serum Ca concentration >2.25mmol/L Ref: Harrison’s 18th edition
  • 13.
    Effect on serumlevels: decrease Ca, increase P Target organ Action Bone Supresses resorption Kidney Increase excretion of Ca
  • 14.
    Alkaline Phosphate Present in alltissue, concentrated in liver, intestins, kidney, bone and placenta  Normal range: 20 – 140 IU/L
  • 15.
    Recent Markers Osteoblast s Osteoi d Osteocyt e Bone matrix Osteocla st Markers ofbone resorption (Urine) Hydroxyproline Collagen cross-links Pyridinolines (pyridinoline, deoxypyridinoline) Cross-linked telopeptides (NTx, CTx) Tartrate-Resistant Acid Posphate Markers of bone formation (serum) Bone alkaline phosphatase Osteocalcin Procollagen type I propeptides (PINP, PICP)
  • 16.
    Disease with markers Disease S.Ca S. PO4 S.PTH S. ALP Recent biomarker Osteoporosis N N N N/high Cathepsin K C- telopeptide Rickets/Osetmalacia Low low high high Osteocalcin Paget’s disease N N N high --------
  • 17.
    Metabolic bone diseases heterogeneous groupof disorders characterized by abnormalities in calciummetabolism and/or bone cell physiology. They lead to analtered serum calcium concentration and/or skeletal failure. The most common type of metabolic bone disease in developed countries is osteoporosis • Osteoporosis • Osteomalacia & Rickets • Renal Osteodystrophy
  • 18.
    Rickets & Osteomalacia Rickets isdefective mineralization of bones before epiphysial closure in immature mammals due to deficiency or impaired metabolism of vitamin D, phosphorus or calcium ,potentially leading to fractures and deformity. Osteomalacia is a similar condition occurring in adults, generally due to a deficiency of vitamin D but occurs after epiphyseal closure.
  • 19.
    Rickets & Osteomalacia Vit Ddeficiency low intake plus inadequate sunlight exposure malabsorption Abnormal vit D metabolism Liver disease Renal disease Drugs(anticonvulsants) Hypophosphatemia Low intake Hypophosphatemic Vitamin D resistant rickets(X- linked)
  • 20.
    • Skeletal deformity Toddlers:Bowed legs (genu varum) Older children: Knock-knees (genu valgum) or "windswept knees" Cranial deformity (such as skull bossing or delayed fontanelle closure) Pelvic deformity Spinal deformity (such as kyphoscoliosis or lumbar lordosis)
  • 26.
    Rickets & Osteomalacia • Labinvestigations include : • S. ALP ↑ • Ca low in Vitamin D deficiency • Phosphate may be normal or low • PTH may ↑
  • 27.
    OSTEOPOR OSIS Common in developedcountries Associated with advanced age Associated with increased risk of fractures (hip, vertebrae, forearm) Exercise & nutrition play an important role in attaining adequate skeletal mass During early adult life bone formation = bone resorption Aging increases bone resorption
  • 29.
    OSTEOPOR OSIS • Pathophysiology  Inadequatebone formation during growth  Pathophysiological process impairing osteoblastic bone formation  Increase in bone resorption
  • 30.
    Factors involved incausation of osteoporosis Hormones Poor diet Genetic factors Cytokines Prostaglandins Growth factors Low physical activity and low exposure to sunlight
  • 31.
    Osteoporo sis • Risk Factors -Early menopause - family history - Sedentary life - Low calcium intake - Cigarette smoking - Excessive alcohol - Excessive - Most commonly encountered in post menopausal females
  • 32.
  • 34.
    Osteoporosis (management)  Exercise  Calcium Vit D  Bisphosponates  Oestrogen replacement  Androgens
  • 35.
    Pagets Disease Disease of boneremodelling osteoclast mediated bone resorption followed by new bone formation Cause unknown ?virus (paramyxovirus) More common in caucasian
  • 36.
    Pagets Disease (clinical manifestation) Bonepain Joint pain Deformity Spontaneous fractures
  • 37.
    Pagets Disease (complications) Fractures Deafness Nerve entrapment Spinalstenosis Cardiac failure Osteogenic sarcoma Hypercalcemia
  • 38.
    Pagets Disease (investigations) ↑ markersof bone formation ↑ ↑ Serum alk phosphatase Urinary hydroxy proline and pyridinoline cross links X-rays cortical thikening osteolytic, & osteiosclerotic  bone scan
  • 39.
    RENAL OSTEODYSTROPHY • Associated withCRF a) ↓excretion of PO4 ---> ↑ PO4 b) Inability of kidney to synthesise 1,25 (OH)2D (↓ renal mass & ↑ PO4) c) ↓ intestinal absorption of Ca ---> hypocalcemia • Results in hyper parathyroidism
  • 41.
    RENAL OSTEODYSTROPHY : CLINICAL MENIFESTATIONS •BONE PAINS (WT BEARING) • SKELETAL DEFORMITIES IN CHILD • EXTRACELLULAR CALCIFICATION
  • 42.
    • LAB INVESTIGATIONS:  ↑PO4  HYPOCALCEMIA  ↑ PTH  ↓1,25 (OH)2 D  ↑ ALP  Mg ↑
  • 44.